Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease

For many patients with sickle cell disease (SCD), jaundice is a significant clinical disease manifestation that impacts on patient well-being. We report a case of a patient with SCD and chronic jaundice treated with voxelotor (GBT440), a novel small molecule hemoglobin oxygen affinity modulator and...

Descripción completa

Detalles Bibliográficos
Autores principales: Telfer, Paul, Agodoa, Irene, Fox, Kathleen M., Burke, Laurie, Mant, Timothy, Jurek, Marzena, Tonda, Margaret, Lehrer-Graiwer, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036983/
https://www.ncbi.nlm.nih.gov/pubmed/30046415
http://dx.doi.org/10.4081/hr.2018.7643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036983/
https://www.ncbi.nlm.nih.gov/pubmed/30046415
http://dx.doi.org/10.4081/hr.2018.7643

Ejemplares similares